(VIANEWS) – MAGNORA (MGN.OL), EDP RENOVAVEIS (EDPR.LS), TIPIAK (TIPI.PA) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. MAGNORA (MGN.OL)
990.5% sales growth and 10.56% return on equity
Magnora ASA operates as a renewable energy development company. It primarily focuses on developing wind and solar photovoltaic (PV) projects. The company also hold license agreements with the Dana Western Isles and Shell Penguins FPSO. It serves oil companies and marine contractors in the United Kingdom, Norway, and Sweden. The company was formerly known as Sevan Marine ASA and changed its name to Magnora ASA in October 2018. Magnora ASA was incorporated in 2001 and is based in Oslo, Norway.
Earnings Per Share
As for profitability, MAGNORA has a trailing twelve months EPS of kr0.76.
PE Ratio
MAGNORA has a trailing twelve months price to earnings ratio of 39.87. Meaning, the purchaser of the share is investing kr39.87 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.56%.
Sales Growth
MAGNORA’s sales growth for the next quarter is 990.5%.
More news about MAGNORA.
2. EDP RENOVAVEIS (EDPR.LS)
20.1% sales growth and 7.23% return on equity
EDP Renováveis, S.A., a renewable energy company, plans, constructs, operates, and maintains electric power generation plants. The company operates wind and solar farms. As of December 31, 2021, it had an installed capacity of 5,908 megawatts in the United States; 2,194 megawatts in Spain; 795 megawatts in Brazil; and 1,142 megawatts in Portugal. The company was incorporated in 2007 and is headquartered in Madrid, Spain. EDP Renováveis, S.A. operates as a subsidiary of EDP-Energias de Portugal, S.A.
Earnings Per Share
As for profitability, EDP RENOVAVEIS has a trailing twelve months EPS of €0.62.
PE Ratio
EDP RENOVAVEIS has a trailing twelve months price to earnings ratio of 31.32. Meaning, the purchaser of the share is investing €31.32 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.23%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is a negative 90.6% and a negative 14.3%, respectively.
Yearly Top and Bottom Value
EDP RENOVAVEIS’s stock is valued at €19.42 at 22:20 EST, way below its 52-week high of €26.87 and above its 52-week low of €18.65.
More news about EDP RENOVAVEIS.
3. TIPIAK (TIPI.PA)
13.7% sales growth and 6.82% return on equity
Tipiak Société Anonyme, a food company, manufactures prepared food products, frozen ready-meals, pastry products, groceries, and crusty bread products. The company offers groceries, such as breadcrumbs, cereals, couscous, croutons, Japanese pearls, potato starch, quinoa, and tapioca; frozen products, including savory products, appetizers, and side dishes with grains; and frozen sweet products comprising macarons, mini eclairs, and petits fours. It sells its products in France, England, and the United States. The company was founded in 1830 and is based in Saint-Aignan-Grandlieu, France.
Earnings Per Share
As for profitability, TIPIAK has a trailing twelve months EPS of €3.7.
PE Ratio
TIPIAK has a trailing twelve months price to earnings ratio of 16.22. Meaning, the purchaser of the share is investing €16.22 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.82%.
More news about TIPIAK.
4. SONAE (SON.LS)
10.8% sales growth and 10.2% return on equity
Sonae, SGPS, S.A. engages in retail, financial services, technology, shopping center, and telecommunications businesses. The company operates hypermarkets under the Continente brand; convenience supermarkets under the Continente Modelo and Continente Bom Dia brands; franchised supermarkets under the Meu Super brand; cafeteria under the Bagga brand; healthy food supermarkets and restaurants under the Go Natural brand; book shops and stationery under the Make Notes and Note! brands; health, well-being, and eye care centers under the Well´s brand; and dental and aesthetic medicine clinics under the Dr. Well's brand, as well as provides dog and cat products and services under the ZU brand. It also offers clothing, footwear, and accessories under the MO brand; baby and children clothing, footwear, and accessories, as well as childcare products under the Zippy and Losan brands; and jeans, clothing, and accessories under the Salsa brand. In addition, the company sells consumer electronics and entertainment products under the Worten brand; and mobile telecommunications products under the Worten Mobile brand, as well as develops real estate properties. Further, it offers payments, cards, personal loans, and insurance under the Universo brand; financing online purchases under the Universo Flex brand; and meal vouchers, gifting, and rewarding under the Da cards brand, as well as operates sports retail stores under JD, Sprinter, and Size? brand names. Additionally, the company provides telecommunication services to residential, personal, corporate, and wholesale markets; and investment management activities. It operates in Portugal, Spain, France, the United Kingdom, Germany, Italy, Romania, Brazil, Mexico, the Netherlands, and internationally. Sonae, SGPS, S.A. was founded in 1959 and is headquartered in Maia, Portugal. Sonae, SGPS, S.A. is a subsidiary of Efanor Investimentos SGPS, SA.
Earnings Per Share
As for profitability, SONAE has a trailing twelve months EPS of €0.14.
PE Ratio
SONAE has a trailing twelve months price to earnings ratio of 6.64. Meaning, the purchaser of the share is investing €6.64 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.2%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on May 12, 2023, the estimated forward annual dividend rate is 0.05 and the estimated forward annual dividend yield is 5.69%.
Sales Growth
SONAE’s sales growth is negative 5.7% for the present quarter and 10.8% for the next.
More news about SONAE.
5. NAVAMEDIC (NAVA.OL)
9.6% sales growth and 22.97% return on equity
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, obesity, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr1.7.
PE Ratio
NAVAMEDIC has a trailing twelve months price to earnings ratio of 22.82. Meaning, the purchaser of the share is investing kr22.82 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.97%.
More news about NAVAMEDIC.
6. ORKLA (ORK.OL)
8.3% sales growth and 12.65% return on equity
Orkla ASA engages in branded consumer goods, and industrial and financial investment businesses. The company offers branded products, including frozen pizza, ketchup, soups, sauces, bread toppings, and ready-to-eat meals through grocery channels, as well as food service, convenience stores, and petrol stations. It also provides confectionery, biscuit, and snack products; and develops bran and crispbread products, as well as energy snack meals. In addition, the company offers personal care and cleaning products; dietary supplement, sport nutrition, and weight control products; wound care products and first aid equipment; painting tools; basic and wool garments for men, women, and children; and professional cleaning products. Further, it operates Gymgrossisten, Proteinfabrikken, Bodystore, and Fitnessmarket e-commerce portals for health and sports nutrition products; and restaurants. Additionally, the company supplies margarine and butter blends, bread and cake improvers and mixes, yeast, marzipan, and ice cream ingredients; produces and supplies hydro power to the Nordic power market; and develops and sells real estate properties. It offers its food products under the Grandiosa, TORO, Stabburet, Felix, Paulúns, NATURLI', Abba, Beauvais, Den Gamle Fabrik, Spilva, and Vitana brands; confectionery and snacks under the KiMs, Nidar, Stratos, Sætre, Göteborgs Kex, OLW, Panda, Laima, Selga, Taffel, Kalev, and Nói Síríus brands; health and sports nutrition under e Zalo, Jif, Bliw, Grumme, Blenda, Define, Möller's, Collett, Nutrilett, Maxim, Norgesplaster, and Salvequick brands; and food ingredients under the Odense, Mors Hjemmebakte, KronJäst, Bakkedal, and NATURLI brands. It has operations in Norway, Sweden, Denmark, Finland, Iceland, the Baltics, rest of Europe, and internationally. The company was founded in 1918 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, ORKLA has a trailing twelve months EPS of kr5.23.
PE Ratio
ORKLA has a trailing twelve months price to earnings ratio of 14.78. Meaning, the purchaser of the share is investing kr14.78 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.65%.
More news about ORKLA.
7. PERNOD RICARD (RI.PA)
7.9% sales growth and 14.84% return on equity
Pernod Ricard SA produces and sells wines and spirits worldwide. The company offers whiskey, vodka, gin, rum, liqueur and bitters, champagne, tequila and mezcal, and aperitif under the brands 100 Pipers, Aberlour, Absolut, Absolut Elyx, Altos, ARARAT, Augier, Avion, Ballantine's, Becherovka, Beefeater, Blenders Pride, Brancott Estate, Campo Viejo, Ceder's, Chivas, Church Road, Clan Campbell, Del Maguey, George Wyndham, Green Spot, Havana Club, Imperial, Imperial Blue, Italicus, J.P. Wiser's, Jacob's Creek, Jameson, Jefferson's, Kahlúa, Kenwood, KI NO BI, Lillet, Long John, L'Orbe, Lot No. 40, Malfy, Malibu, Martell, Method & Madness, Midleton Very Rare, Minttu, Monkey 47, Mumm, Olmeca, Ostoya, Passport Scotch, Pastis 51, Pernod, Perrier-Jouët, Plymouth Gin, Powers, Rabbit Hole, Ramazzotti, Redbreast, Ricard, Royal Salute, Royal Stag, Scapa, Seagram's Gin, Secret Speyside, Smooth Ambler, Something Special, St Hugo, Stoneleigh, Suze, The Glenlivet, TX, Wyborowa, and Ysios. It also provides non-alcoholic beverages under the brands Ceder's, Suze Tonic 0%, Cinzano Spritz 0%, Pacific, Campo Viejo Sparkling 0%, and Jacob's Creek Unvined. The company was founded in 1805 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, PERNOD RICARD has a trailing twelve months EPS of €9.32.
PE Ratio
PERNOD RICARD has a trailing twelve months price to earnings ratio of 21.48. Meaning, the purchaser of the share is investing €21.48 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.84%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 19.4%, now sitting on 11.86B for the twelve trailing months.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Jul 5, 2023, the estimated forward annual dividend rate is 4.62 and the estimated forward annual dividend yield is 2.31%.
Moving Average
PERNOD RICARD’s value is under its 50-day moving average of €209.73 and above its 200-day moving average of €193.80.
Yearly Top and Bottom Value
PERNOD RICARD’s stock is valued at €200.20 at 22:20 EST, below its 52-week high of €218.00 and way higher than its 52-week low of €166.60.
More news about PERNOD RICARD.
